The 5HT3 Receptor Antagonist Ondansetron Can Have an Analgesic Effect in Chronic Human Neuropathic Pain
Journal of Neuropathic Pain & Symptom Palliation · 2005
DOI: 10.3109/j426v01n01_12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathic Pain & Symptom Palliation, 2005. Verfasst von Gary McCleane und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
McCleane, G., Suzuki, R., & Dickenson, A. (2005). The 5HT3 Receptor Antagonist Ondansetron Can Have an Analgesic Effect in Chronic Human Neuropathic Pain. Journal of Neuropathic Pain & Symptom Palliation. https://doi.org/10.3109/j426v01n01_12
Vancouver
McCleane G, Suzuki R, Dickenson A. The 5HT3 Receptor Antagonist Ondansetron Can Have an Analgesic Effect in Chronic Human Neuropathic Pain. Journal of Neuropathic Pain & Symptom Palliation. 2005. doi:10.3109/j426v01n01_12
BibTeX
@article{McCleane2005,
author = {McCleane, Gary and Suzuki, Rie and Dickenson, Anthony},
title = {The 5HT3 Receptor Antagonist Ondansetron Can Have an Analgesic Effect in Chronic Human Neuropathic Pain},
journal = {Journal of Neuropathic Pain & Symptom Palliation},
year = {2005},
doi = {10.3109/j426v01n01_12}
}
EUVIMED